X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-08 | EHAB | Bolton Jeffrey | Dir | P - Purchase | $7.72 | +10,000 | 94,144 | +12% | +$77,177 | |||||
2024-08-22 | EHAB | Bolton Jeffrey | Dir | P - Purchase | $8.01 | +5,000 | 78,877 | +7% | +$40,050 | ||||||
| M | 2024-08-08 | EHAB | Bolton Jeffrey | Dir | P - Purchase | $8.38 | +7,000 | 73,877 | +10% | +$58,650 | |||||
2024-05-17 | EHAB | Bolton Jeffrey | Dir | P - Purchase | $8.33 | +10,000 | 52,299 | +24% | +$83,300 | ||||||
2024-05-14 | EHAB | Hoeflinger Erin | Dir | P - Purchase | $9.00 | +2,000 | 30,399 | +7% | +$18,000 | ||||||
2024-05-10 | EHAB | Bolton Jeffrey | Dir | P - Purchase | $8.24 | +10,000 | 42,299 | +31% | +$82,400 | ||||||
2024-03-01 | EHAB | Langham Ronald Leroy Jr | EVP Clinical Excel., Strategy | S - Sale | $8.81 | -634 | 57,164 | -1% | -$5,586 | ||||||
2023-05-26 | EHAB | Bolton Jeffrey | Dir | P - Purchase | $11.61 | +2,000 | 19,597 | +11% | +$23,220 | ||||||
2023-05-22 | EHAB | Shaw L Edward Jr | Dir | P - Purchase | $11.98 | +10,000 | 38,989 | +34% | +$119,800 | ||||||
2023-05-18 | EHAB | Hoeflinger Erin | Dir | P - Purchase | $11.82 | +2,100 | 15,697 | +15% | +$24,822 | ||||||
2023-05-18 | EHAB | Langham Ronald Leroy Jr | EVP Clinical Excel., Strategy | P - Purchase | $11.99 | +10,000 | 44,328 | +29% | +$119,900 | ||||||
2023-05-17 | EHAB | Bolton Jeffrey | Dir | P - Purchase | $11.80 | +2,000 | 17,597 | +13% | +$23,600 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |